Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADVFN Regulatory News (AFN)

  • There is currently no data for AFN

Corporate Update

18 Apr 2018 17:35

RNS Number : 3854L
ADVFN PLC
18 April 2018
 

 

For immediate release

 

18 April 2018

 

ADVFN PLC

 ("ADVFN" or the "Company")

Corporate Update

 

The Board of ADVFN announced in November 2017 that ADVFN had formed a new venture, MJAC InvestorsHub International Conferences Limited ("MJAC InvestorsHub"), to develop conference and new exhibition opportunities. USA-based THC Therapeutics, Inc, now re-named Millenium Blockchain, ("MBLC"), had agreed to take a 50% interest in MJAC InvestorsHub. As MBLC has not to date completed its planned investment in MJAC InvestorsHub, the Board of ADVFN has decided to terminate the joint venture arrangements and continue to develop MJAC InvestorsHub as a wholly-owned venture. The next MJAC InvestorsHub conference, the "Blockchain Summit" is being held at Old Billingsgate in London on 13 June 2018. The Blockchain Summit is expected to have in excess of 50 corporate exhibitors together with pioneers, innovators and thought-leaders in the blockchain industry to examine all aspects of the blockchain industry. Further information about this event can be found at https://mjac.io

 

More information on ADVFN can be found at: www.ADVFN.com.

 

For further information please contact: 

 

ADVFN PLC

Clem Chambers, CEO

 

+44 (0) 207 070 0909

Beaumont Cornish Limited (Nominated Adviser)

www.beaumontcornish.com

Roland Cornish / Michael Cornish

+44 (0) 207 628 3396

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDQVLFFVZFXBBL
Date   Source Headline
11th Jan 202310:49 amRNSHolding(s) in Company
11th Jan 202310:49 amRNSHolding(s) in Company
10th Jan 20237:00 amRNSCorporate update
9th Jan 20235:22 pmRNSTotal voting rights, Director / PDMR shareholding
6th Jan 20232:04 pmRNSFinal Results of Open Offer
6th Jan 20237:00 amRNSResults of Open Offer
20th Dec 20227:00 amRNSOpen Offer timetable and AGM
6th Dec 20227:00 amRNSOpen Offer
6th Dec 20227:00 amRNSFinal Results
28th Nov 20227:00 amRNSCorporate update
15th Sep 202210:45 amRNSAppointment of joint corporate broker
19th Aug 20224:15 pmRNSCorporate update
8th Aug 20227:00 amRNSDirectorate Change
6th Jun 20227:00 amRNSTrading and Corporate Update
29th Apr 20222:05 pmRNSResult of Meeting
28th Apr 20224:41 pmRNSSecond Price Monitoring Extn
28th Apr 20224:35 pmRNSPrice Monitoring Extension
28th Apr 20222:01 pmRNSHolding(s) in Company
22nd Apr 20224:00 pmRNSTotal Voting Rights
20th Apr 202211:05 amRNSSecond Price Monitoring Extn
20th Apr 202211:00 amRNSPrice Monitoring Extension
13th Apr 20229:29 amRNSHolding(s) in Company
4th Apr 202212:25 pmRNSNotice of GM
28th Mar 20228:04 amRNSCorporate Update
22nd Mar 20227:00 amRNSWinners of Financial Awards 2022 Announced
17th Mar 20223:32 pmRNSHolding(s) in Company
17th Mar 20223:32 pmRNSHolding(s) in Company
16th Mar 202210:29 amRNSHolding(s) in Company
9th Mar 20227:00 amRNSCorporate Update
3rd Mar 20225:20 pmRNSCorporate Update
25th Feb 20222:02 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSBoard change
23rd Feb 20227:00 amRNSCorporate Update
21st Feb 20227:00 amRNSHalf-year Report
14th Feb 20229:21 amRNSRequisition of general meeting update
8th Feb 202210:54 amRNSStrategic review and end of formal sales process
3rd Feb 202210:47 amRNSForm 8.3 - ADVFN PLC
26th Jan 20221:15 pmRNSRequisition of General Meeting
26th Jan 20227:00 amRNSBest Global Private Investor Multi-Market Informat
24th Jan 20229:35 amRNSForm 8.3 - ADVFN plc
21st Jan 20223:14 pmRNSForm 8.3 - ADVFN plc
19th Jan 20225:03 pmRNSForm 8.3 - ADVFN plc
19th Jan 20224:53 pmRNSForm 8.3 - ADVFN PLC
18th Jan 20227:00 amRNSForm 8 (OPD) ADVFN plc
13th Jan 20227:00 amRNSStrategic review and formal sales process
29th Dec 20215:19 pmRNSHolding(s) in Company
29th Dec 20215:15 pmRNSHolding(s) in Company
23rd Dec 20213:28 pmRNSResult of AGM
22nd Nov 20211:08 pmRNSHolding(s) in Company - Replacement
22nd Nov 202111:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.